Publications by authors named "Adam Sheehy"

Claim this Profile
V
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1 ALS mouse model.
Zachary C E Hawley, Xueying Li, Dora Bodnar, Yuanzheng Gu, Yi Luo, Adam Sheehy

Acta Neuropathol Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model.
Yi A Chen, Mark W Kankel, Sam Hana, Shukkwan Kelly Lau, Maria I Zavodszky, Adam Sheehy

Gene Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
Haiyan Peng, Huo Li, Adam Sheehy, Patrick Cullen, Norm Allaire

J Neuroimmunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.
Michael Hedvat, Dennis Huszar, Andreas Herrmann, Joseph M Gozgit, Anne Schroeder, Adam Sheehy

Cancer Cell· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.
Sonya D Zabludoff, Chun Deng, Michael R Grondine, Adam M Sheehy, Susan Ashwell

Mol Cancer Ther· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis